We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
(-17%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$364M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$155M |
| 3 |
Textron
TXT
|
+$103M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$102M |
| 5 |
Sanofi
SNY
|
+$96.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$333M |
| 2 |
ExxonMobil
XOM
|
+$242M |
| 3 |
Dollar Tree
DLTR
|
+$231M |
| 4 |
Nutrien
NTR
|
+$213M |
| 5 |
National Vision
EYE
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.53% |
| 2 | Healthcare | 17.73% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1101
National Vision
EYE
$1.77B
| – | – |
-4,535,332
| Closed | -$198M |
|
1102
FIVE9
FIVN
$2.11B
| – | – |
-55,000
| Closed | -$6.07M |
|
|
FOXO
1103
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
| – | – |
-6,030
| Closed | -$11.9M |
|
1104
American Express Global Business Travel
GBTG
$4.93B
| – | – |
-1,155,600
| Closed | -$11.5M |
|
1105
GH Research
GHRS
$1.93B
| – | – |
-150,000
| Closed | -$2.74M |
|
1106
Hess Midstream
HESM
$5.24B
| – | – |
-350,000
| Closed | -$10.5M |
|
1107
Hubbell
HUBB
$25B
| – | – |
-60,000
| Closed | -$11M |
|
1108
Invitation Homes
INVH
$17.7B
| – | – |
-30,700
| Closed | -$1.23M |
|
1109
Samsara
IOT
$21.7B
| – | – |
-400,000
| Closed | -$6.41M |
|
1110
IPG Photonics
IPGP
$3.61B
| – | – |
-8,400
| Closed | -$922K |
|
|
ITOS
1111
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-105,000
| Closed | -$3.38M |
|
1112
Kimberly-Clark
KMB
$36.3B
| – | – |
-109,333
| Closed | -$13.5M |
|
1113
Kearny Financial
KRNY
$604M
| – | – |
-436,700
| Closed | -$5.63M |
|
1114
Kymera Therapeutics
KYMR
$8.51B
| – | – |
-180,000
| Closed | -$7.62M |
|
1115
Cheniere Energy
LNG
$55.2B
| – | – |
-135,000
| Closed | -$18.7M |
|
1116
Live Nation Entertainment
LYV
$40.6B
| – | – |
-46,100
| Closed | -$5.42M |
|
1117
Seres Therapeutics
MCRB
$46.8M
| – | – |
-15,000
| Closed | -$2.14M |
|
1118
Madrigal Pharmaceuticals
MDGL
$10.8B
| – | – |
-77,331
| Closed | -$7.59M |
|
1119
Monro
MNRO
$383M
| – | – |
-493,695
| Closed | -$21.9M |
|
1120
MaxLinear
MXL
$6.06B
| – | – |
-779,151
| Closed | -$45.5M |
|
1121
NextDecade
NEXT
$1.79B
| – | – |
-266,745
| Closed | -$1.77M |
|
|
1122
Nutrien
NTR
$33.2B
| – | – |
-2,050,000
| Closed | -$213M |
|
1123
OGE Energy
OGE
$9.78B
| – | – |
-100,000
| Closed | -$4.08M |
|
1124
Olin
OLN
$2.11B
| – | – |
-100,000
| Closed | -$5.23M |
|
1125
Otis Worldwide
OTIS
$27.4B
| – | – |
-278,289
| Closed | -$21.4M |
|
Similar funds
Adage Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.
- Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
- Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
- Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
- Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
- Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
- Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
- Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.
Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.